Adagene (ADAG)
(Real Time Quote from BATS)
$3.30 USD
+0.31 (10.37%)
Updated Sep 13, 2024 01:18 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Balance Sheet
Fiscal Year End for Adagene Inc Sponsored ADR falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 110 | 144 | 174 | 75 | 101 |
Receivables | 0 | 1 | 8 | 0 | 2 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 3 | 5 | 4 | 4 | 1 |
Total Current Assets | 113 | 149 | 186 | 79 | 104 |
Net Property & Equipment | 2 | 3 | 3 | 2 | 2 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 3 | 0 |
Total Assets | 116 | 152 | 190 | 84 | 106 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 4 | 11 | 3 | 4 | 1 |
Accounts Payable | 3 | 4 | 3 | 2 | 1 |
Current Portion Long-Term Debt | 4 | 3 | 1 | 1 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 3 | 4 | 6 | 3 |
Income Taxes Payable | 0 | 0 | 2 | 0 | 0 |
Other Current Liabilities | 17 | 34 | 16 | 3 | 3 |
Total Current Liabilities | 31 | 55 | 30 | 16 | 7 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 14 | 14 | 3 | 3 | 2 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 154 | 154 |
Total Liabilities | 45 | 69 | 33 | 174 | 163 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 350 | 343 | 336 | 24 | 7 |
Retained Earnings | -278 | -259 | -179 | -106 | -63 |
Other Equity | -2 | -1 | 0 | -8 | -1 |
Treasury Stock | 0 | 0 | 1 | 0 | 0 |
Total Shareholder's Equity | 71 | 83 | 157 | -89 | -57 |
Total Liabilities & Shareholder's Equity | 116 | 152 | 190 | 84 | 106 |
Total Common Equity | 71 | 83 | 157 | -89 | -57 |
Shares Outstanding | 43.80 | 43.40 | 43.60 | NA | NA |
Book Value Per Share | 1.61 | 1.91 | 3.59 | 0.00 | 0.00 |
Fiscal Year End for Adagene Inc Sponsored ADR falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,903 | -99,999 | 110 | -99,999 | -99,870 |
Receivables | 0 | NA | 0 | NA | 0 |
Notes Receivable | NA | NA | 0 | NA | NA |
Inventories | NA | NA | 0 | NA | NA |
Other Current Assets | 3 | NA | 3 | NA | 4 |
Total Current Assets | 99 | NA | 113 | NA | 133 |
Net Property & Equipment | 1 | NA | 2 | NA | 2 |
Investments & Advances | NA | NA | 0 | NA | NA |
Other Non-Current Assets | NA | NA | 0 | NA | NA |
Deferred Charges | NA | NA | 0 | NA | NA |
Intangibles | NA | NA | 0 | NA | NA |
Deposits & Other Assets | 0 | NA | 0 | NA | 0 |
Total Assets | 101 | NA | 116 | NA | 135 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 4 | NA | 4 | NA | 9 |
Accounts Payable | 3 | NA | 3 | NA | 4 |
Current Portion Long-Term Debt | 12 | NA | 4 | NA | 3 |
Current Portion Capital Leases | NA | NA | 0 | NA | NA |
Accrued Expenses | 3 | NA | 3 | NA | 3 |
Income Taxes Payable | 0 | NA | 0 | NA | 2 |
Other Current Liabilities | 17 | NA | 17 | NA | 18 |
Total Current Liabilities | 40 | NA | 31 | NA | 39 |
Mortgages | NA | NA | 0 | NA | NA |
Deferred Taxes/Income | NA | NA | 0 | NA | NA |
Convertible Debt | NA | NA | 0 | NA | NA |
Long-Term Debt | 5 | NA | 14 | NA | 13 |
Non-Current Capital Leases | NA | NA | 0 | NA | NA |
Other Non-Current Liabilities | NA | 0 | NA | 0 | |
Minority Interest (Liabilities) | NA | NA | 0 | NA | NA |
Total Liabilities | 44 | NA | 45 | NA | 53 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | NA | NA |
Common Stock (Par) | 0 | NA | 0 | NA | 0 |
Capital Surplus | 353 | NA | 350 | NA | 347 |
Retained Earnings | -295 | NA | -278 | NA | -263 |
Other Equity | -1 | NA | -2 | NA | -1 |
Treasury Stock | 0 | NA | 0 | NA | 0 |
Total Shareholder's Equity | 57 | NA | 71 | NA | 83 |
Total Liabilities & Shareholder's Equity | 101 | NA | 116 | NA | 135 |
Total Common Equity | 100,056 | 0 | 71 | 0 | 100,082 |
Shares Outstanding | 44.10 | 44.10 | 43.80 | 43.80 | 43.70 |
Book Value Per Share | 2,268.83 | 0.00 | 1.61 | 0.00 | 2,290.20 |